Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
Flinders University · University of South Australia
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
540
total citations
- FWCI
- 26.55
- Percentile
- 100%
- References
- 26
Citations per year
Authors
6Topics & keywords
Topics
Keywords
- KRAS
- Neuroblastoma RAS viral oncogene homolog
- Medicine
- Colorectal cancer
- Exon
- Cetuximab
- Cancer research
- Epidermal growth factor receptor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.